TSS
LLY icon

Two Sigma Securities’s Eli Lilly LLY Stock Holding History

Two Sigma Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300
Closed -$232K – 1879
2024
Q4 		$232K Sell
300
-25,800
-99% -$21.4M 0.03% 850
2024
Q3 		$23.1M Sell
26,100
-22,800
-47% -$20.5M 0.39% 44
2024
Q2 		$44.3M Sell
48,900
-18,800
-28% -$15M 0.53% 25
2024
Q1 		$52.7M Buy
67,700
+13,300
+24% +$9.47M 0.51% 25
2023
Q4 		$31.7M Buy
54,400
+17,700
+48% +$10.3M 0.31% 52
2023
Q3 		$19.7M Buy
36,700
+12,600
+52% +$6.49M 0.21% 93
2023
Q2 		$11.3M Hold
24,100
– – 0.17% 128
2023
Q1 		$8.28M Buy
24,100
+12,000
+99% +$4.05M 0.17% 129
2022
Q4 		$4.43M Buy
12,100
+9,600
+384% +$3.4M 0.13% 174
2022
Q3 		$808K Buy
2,500
+500
+25% +$158K 0.02% 768
2022
Q2 		$648K Sell
2,000
-3,200
-62% -$961K 0.02% 737
2022
Q1 		$1.49M Buy
+5,200
New +$1.34M 0.05% 446
2021
Q4 		– Sell
-7,600
Closed -$1.76M – 1819
2021
Q3 		$1.76M Sell
7,600
-5,400
-42% -$1.33M 0.05% 315
2021
Q2 		$2.98M Buy
+13,000
New +$2.61M 0.09% 161
2021
Q1 		– Sell
-4,400
Closed -$743K – 1353
2020
Q4 		$743K Sell
4,400
-300
-6% -$44.8K 0.02% 498
2020
Q3 		$696K Sell
4,700
-3,800
-45% -$588K 0.01% 473
2020
Q2 		$1.4M Buy
8,500
+1,100
+15% +$169K 0.03% 305
2020
Q1 		$1.03M Sell
7,400
-114,000
-94% -$15.7M 0.02% 383
2019
Q4 		$16M Buy
121,400
+113,200
+1,380% +$13.1M 0.11% 136
2019
Q3 		$917K Sell
8,200
-21,800
-73% -$2.43M 0.01% 916
2019
Q2 		$3.32M Buy
30,000
+27,600
+1,150% +$3.25M 0.03% 323
2019
Q1 		$311K Sell
2,400
-6,300
-72% -$766K ﹤0.01% 1168
2018
Q4 		$1.01M Sell
8,700
-89,100
-91% -$9.95M 0.01% 636
2018
Q3 		$10.5M Buy
97,800
+22,300
+30% +$2.23M 0.07% 199
2018
Q2 		$6.44M Sell
75,500
-8,000
-10% -$657K 0.03% 400
2018
Q1 		$6.46M Buy
+83,500
New +$6.72M 0.04% 400

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Securities's LLY Position: Q1 2026 in Review

Two Sigma Securities sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,877 shares — an estimated $2.02M sold.

Two Sigma Securities first reported a position in LLY in Q3 2016 and held it in 23 quarters. The position peaked at $59.2M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Two Sigma Securities reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,877 Eli Lilly shares in Q1 2026, an estimated $2.02M.
  • Two Sigma Securities first reported a position in Eli Lilly in Q3 2016 and held it in 23 quarters.
  • Two Sigma Securities's Eli Lilly position peaked at $59.2M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.